The Global Organoids and Spheroids Market was valued at USD 1,245.67 million in 2024 and is projected to reach USD 10,461.78 million by 2035. This remarkable growth reflects a strong CAGR of 22.05% during the forecast period, driven by increasing adoption in drug discovery and personalized medicine.
Rising Demand for Personalized Medicine
The focus on personalized medicine is really driving the Global Organoids and Spheroids Market forward. This is because organoids can be used to model diseases in a way that's specific to each patient, and to test drugs in a targeted way. Their ability to closely replicate human organ functionality enhances treatment precision and improves clinical outcomes.
Segment-Wise Market Breakdown
Type
• Organoids: Advanced 3D models mimicking human organ functions
• Spheroids: Simple cell clusters for basic biological studies
Source
• Human Tissue: Highly relevant models for personalized research applications
• Animal Tissue: Cost-effective models for preliminary experimental studies
• Synthetic: Engineered sources enabling scalable and controlled production
Application
• Drug Discovery: Accelerates identification of effective therapeutic compounds
• Toxicology Testing: Enables accurate assessment of drug safety profiles
• Regenerative Medicine: Supports development of tissue repair solutions
• Cancer Research: Facilitates tumor modeling and targeted therapy testing
• Stem Cell Research: Advances understanding of cell differentiation processes
• Others: Includes diverse emerging biomedical research applications
End User
• Pharmaceutical and Biotechnology Companies: Major adopters for drug development processes
• Hospitals and Diagnostic Centers: Utilize models for clinical and diagnostic insights
• Research and Academic Institutions: Drive innovation through extensive scientific studies
Regional Market Snapshot
North America is currently leading the way. This is due to the strong funding for research and development, the advanced biotech infrastructure, and the supportive regulatory environment. On the other hand, the Asia-Pacific region is growing the fastest, driven by government investments and the expanding contract research organization (CRO) sector. Europe is holding steady, while the Middle East, Africa, and South America are showing gradual growth, supported by innovation, healthcare needs, and cost-effective research models.
Strategic Product Innovation
For example, in July 2023, Molecular Devices LLC launched a custom organoid line expansion service. This service uses advanced bioprocess technology to support the production of organoids on a large scale, in a way that's efficient and scalable. One of the key advantages of the market is its ability to support personalized treatment approaches through models derived from patients.
Expanding Role in Personalized Medicine
The Global Organoids and Spheroids Market is poised for significant growth, driven by its ability to support personalized medicine and targeted therapy development. This capability allows for targeted therapy development, positioning organoids and spheroids as critical tools in next-generation healthcare solutions.
Key Report Attributes
• Market Size 2024: USD 1245.67 Million
• Market Size 2035: USD 10461.78 Million
• CAGR (2025-2035): 22.05%
• Base Year: 2024
• Market Forecast Period: 2025-2035
Industry Segmentations Growth
• By Type: Organoids - 22.39%, Spheroids - 21.56%.
• By Source: Human Tissue - 21.52%, Animal Tissue - 21.89%.
• By Application: Drug Discovery - 23.91%, Toxicology Testing - 19.03%.
• By End User: Pharmaceutical and Biotechnology Companies - 21.18%, Hospitals and Diagnostic Centers - 22.24%.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 35
TABLE 2 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 53
TABLE 3 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR ORGANOIDS, BY REGION, 2019–2035 (USD MILLION) 53
TABLE 4 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR SPHEROIDS, BY REGION, 2019–2035 (USD MILLION) 54
TABLE 5 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 56
TABLE 6 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR HUMAN TISSUE, BY REGION, 2019–2035 (USD MILLION) 56
TABLE 7 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR ANIMAL TISSUE, BY REGION, 2019–2035 (USD MILLION) 57
TABLE 8 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR SYNTHETIC, BY REGION, 2019–2035 (USD MILLION) 57
TABLE 9 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 60
TABLE 10 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR DRUG DISCOVERY, BY REGION, 2019–2035 (USD MILLION) 61
TABLE 11 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR TOXICOLOGY TESTING, BY REGION, 2019–2035 (USD MILLION) 61
TABLE 12 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR REGENERATIVE MEDICINE, BY REGION, 2019–2035 (USD MILLION) 62
TABLE 13 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR CANCER RESEARCH, BY REGION, 2019–2035 (USD MILLION) 62
TABLE 14 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR STEM CELL RESEARCH, BY REGION, 2019–2035 (USD MILLION) 63
TABLE 15 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD MILLION) 63
TABLE 16 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 66
TABLE 17 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2035 (USD MILLION) 67
TABLE 18 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2019–2035 (USD MILLION) 67
TABLE 19 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR RESEARCH AND ACADEMIC INSTITUTIONS, BY REGION, 2019–2035 (USD MILLION) 68
TABLE 20 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY REGION, 2019-2035 (USD MILLION) 69
TABLE 21 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 71
TABLE 22 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 72
TABLE 23 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 72
TABLE 24 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 72
TABLE 25 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 73
TABLE 26 US: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 73
TABLE 27 US: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 73
TABLE 28 US: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 74
TABLE 29 US: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 74
TABLE 30 CANADA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 74
TABLE 31 CANADA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 75
TABLE 32 CANADA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 75
TABLE 33 CANADA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 76
TABLE 34 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 77
TABLE 35 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 78
TABLE 36 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 78
TABLE 37 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 79
TABLE 38 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 79
TABLE 39 GERMANY: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 79
TABLE 40 GERMANY: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 80
TABLE 41 GERMANY: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 80
TABLE 42 GERMANY: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 81
TABLE 43 FRANCE: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 81
TABLE 44 FRANCE: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 81
TABLE 45 FRANCE: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 82
TABLE 46 FRANCE: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 82
TABLE 47 UK: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 82
TABLE 48 UK: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 83
TABLE 49 UK: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 83
TABLE 50 UK: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 84
TABLE 51 SPAIN: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 84
TABLE 52 SPAIN: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 84
TABLE 53 SPAIN: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 85
TABLE 54 SPAIN: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 85
TABLE 55 ITALY: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 85
TABLE 56 ITALY: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 86
TABLE 57 ITALY: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 86
TABLE 58 ITALY: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 87
TABLE 59 RUSSIA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 87
TABLE 60 RUSSIA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 87
TABLE 61 RUSSIA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 88
TABLE 62 RUSSIA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 88
TABLE 63 REST OF EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 88
TABLE 64 REST OF EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 89
TABLE 65 REST OF EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 89
TABLE 66 REST OF EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 90
TABLE 67 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 91
TABLE 68 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 92
TABLE 69 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 92
TABLE 70 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 93
TABLE 71 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 93
TABLE 72 CHINA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 93
TABLE 73 CHINA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 94
TABLE 74 CHINA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 94
TABLE 75 CHINA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 95
TABLE 76 INDIA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 95
TABLE 77 INDIA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 95
TABLE 78 INDIA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 96
TABLE 79 INDIA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 96
TABLE 80 JAPAN: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 97
TABLE 81 JAPAN: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 97
TABLE 82 JAPAN: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 97
TABLE 83 JAPAN: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 98
TABLE 84 SOUTH KOREA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 98
TABLE 85 SOUTH KOREA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 98
TABLE 86 SOUTH KOREA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 99
TABLE 87 SOUTH KOREA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 99
TABLE 88 MALAYSIA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 100
TABLE 89 MALAYSIA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 100
TABLE 90 MALAYSIA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 100
TABLE 91 MALAYSIA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 101
TABLE 92 THAILAND: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 101
TABLE 93 THAILAND: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 101
TABLE 94 THAILAND: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 102
TABLE 95 THAILAND: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 102
TABLE 96 INDONESIA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 102
TABLE 97 INDONESIA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 103
TABLE 98 INDONESIA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 103
TABLE 99 INDONESIA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 104
TABLE 100 REST OF ASIA-PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 104
TABLE 101 REST OF ASIA-PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 104
TABLE 102 REST OF ASIA-PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 105
TABLE 103 REST OF ASIA-PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 105
TABLE 104 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 107
TABLE 105 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 108
TABLE 106 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 108
TABLE 107 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 109
TABLE 108 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 109
TABLE 109 BRAZIL: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 109
TABLE 110 BRAZIL: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 110
TABLE 111 BRAZIL: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 110
TABLE 112 BRAZIL: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 111
TABLE 113 MEXICO: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 111
TABLE 114 MEXICO: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 111
TABLE 115 MEXICO: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 112
TABLE 116 MEXICO: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 112
TABLE 117 ARGENTINA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 112
TABLE 118 ARGENTINA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 113
TABLE 119 ARGENTINA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 113
TABLE 120 ARGENTINA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 114
TABLE 121 REST OF SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 114
TABLE 122 REST OF SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 114
TABLE 123 REST OF SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 115
TABLE 124 REST OF SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 115
TABLE 125 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 117
TABLE 126 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 117
TABLE 127 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 118
TABLE 128 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 129 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 130 GCC COUNTRIES: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 131 GCC COUNTRIES: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION)
TABLE 132 GCC COUNTRIES: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 133 GCC COUNTRIES: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 134 SOUTH AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 135 SOUTH AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION)
TABLE 136 SOUTH AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 137 SOUTH AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 138 REST OF MEA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 139 REST OF MEA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION)
TABLE 140 REST OF MEA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 141 REST OF MEA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 142 PRODUCT LAUNCH
TABLE 143 MOLECULAR DEVICES, LLC: PRODUCTS/SERVICES OFFERED
TABLE 144 MOLECULAR DEVICES LLC: KEY DEVELOPMENTS
TABLE 145 MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 146 CORNING INCORPORATED: PRODUCTS/ SERVICE OFFERED
TABLE 147 HUB ORGANOIDS: PRODUCTS/SERVICES OFFERED
TABLE 148 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
TABLE 149 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 150 BIO-TECHNE: PRODUCTS OFFERED
TABLE 152 CN BIO INNOVATIONS LTD: PRODUCTS OFFERED
TABLE 153 NEYROBLASTGX: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL ORGANOIDS AND SPHEROIDS MARKET: STRUCTURE 21
FIGURE 2 GLOBAL ORGANOIDS AND SPHEROIDS MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035) 38
FIGURE 3 GLOBAL ORGANOIDS AND SPHEROIDS MARKET DRIVER: IMPACT ANALYSIS 41
FIGURE 4 GLOBAL ORGANOIDS AND SPHEROIDS MARKET RESTRAINT: IMPACT ANALYSIS 43
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ORGANOIDS AND SPHEROIDS MARKET 49
FIGURE 6 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, TYPE SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 52
FIGURE 7 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2024 & 2035 (USD MILLION) 52
FIGURE 8 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY TYPE, 2024 54
FIGURE 9 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, SOURCE SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 55
FIGURE 10 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2024 & 2035 (USD MILLION) 55
FIGURE 11 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY SOURCE, 2024 58
FIGURE 12 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 59
FIGURE 13 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 60
FIGURE 14 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY APPLICATION, 2024 64
FIGURE 15 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, END USER SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 65
FIGURE 16 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2024 & 2035 (USD MILLION) 66
FIGURE 17 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY END USER, 2024 68
FIGURE 18 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY REGION, 2024 & 2035 (USD MILLION) 69
FIGURE 19 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY REGION, 2 024 70
FIGURE 20 NORTH AMERICA MARKET ANALYSIS: ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 70
FIGURE 21 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 71
FIGURE 22 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY COUNTRY, 2024 71
FIGURE 23 EUROPE MARKET ANALYSIS: ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 76
FIGURE 24 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 77
FIGURE 25 EUROPE: ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY COUNTRY, 2024 78
FIGURE 26 ASIA PACIFIC MARKET ANALYSIS: ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 90
FIGURE 27 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 91
FIGURE 28 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY COUNTRY, 2024 92
FIGURE 29 SOUTH AMERICA MARKET ANALYSIS: GLOBAL ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 106
FIGURE 30 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 107
FIGURE 31 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKETSHARE, BY COUNTRY, 2024 (%) 108
FIGURE 32 MIDDLE EAST & AFRICA MARKET ANALYSIS: ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 116
FIGURE 33 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKETSHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 116
FIGURE 34 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKETSHARE, BY COUNTRY, 2024 (%) 117
FIGURE 35 GLOBAL ORGANOIDS AND SPHEROIDS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 125
FIGURE 36 COMPETITOR DASHBOARD: GLOBAL ORGANOIDS AND SPHEROIDS MARKET 126
FIGURE 37 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 131
FIGURE 38 MERCK KGGA: SWOT ANALYSIS 132
FIGURE 39 CORNING INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT 135
FIGURE 40 CORNING INCORPORATED: SWOT ANALYSIS 137
FIGURE 41 HUB ORGANOIDS: SWOT ANALYSIS 140
FIGURE 42 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 44 BIO-TECHNE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 45 3DNAMICS INC.: SWOT ANALYSIS
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們